Boundless Bio, Inc.
BOLD- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001782303
In the last 90 days, Boundless Bio, Inc. insiders filed 4 open-market purchases and 2 sales; 40 institutions reported holding it in 13F filings for Q2 2026, worth $38.3M in total; no superinvestor holds it.
Q2 2024 vs. Q1 2024
How the institutions holding Boundless Bio, Inc. changed between Q1 2024 and Q2 2024.
All holders in Q2 2024All holders in Q1 2024
| Measure | Q1 2024 | Q2 2024 | Change |
|---|---|---|---|
| Holders | 43 | 47 | +4 |
| Shares | 14.6M | 13.8M | −740.4K (−5.1%) |
| Value | $208.8M | $53.4M | −$155.3M (−74.4%) |
New holders (21)
Institutions that held Boundless Bio, Inc. at the end of Q2 2024 but not at the end of Q1 2024.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Morgan Stanley | 186,932 | $723.4K | 0.00% |
| Geode Capital Management, LLC | 110,634 | $428.2K | 0.00% |
| Renaissance Technologies LLC | 45,383 | $175.6K | 0.00% |
| Walleye Capital LLC | 40,539 | $156.9K | 0.00% |
| New York State Common Retirement Fund | 22,100 | $85.5K | 0.00% |
| State Street Corp | 21,265 | $82.3K | 0.00% |
| Bank of America Corp | 17,912 | $69.3K | 0.00% |
| Charles Schwab Investment Management Inc | 14,649 | $56.7K | 0.00% |
| Rhumbline Advisers | 6,228 | $24.1K | 0.00% |
| Corebridge Financial, Inc. | 3,395 | $13.2K | 0.00% |
| Tower Research Capital LLC (TRC) | 3,273 | $12.7K | 0.00% |
| JPMorgan Chase & Co | 2,689 | $10.4K | 0.00% |
| Wells Fargo & Company | 2,317 | $8.97K | 0.00% |
| UBS Group AG | 1,915 | $7.41K | 0.00% |
| Citigroup Inc | 1,406 | $5.44K | 0.00% |
| Ameritas Investment Partners, Inc. | 618 | $2.39K | 0.00% |
| Cubist Systematic Strategies, LLC | 520 | $2.01K | 0.00% |
| BNP Paribas Arbitrage, SA | 500 | $1.94K | 0.00% |
| California State Teachers Retirement System | 457 | $1.77K | 0.00% |
| Amalgamated Bank | 218 | $1.00K | 0.00% |
| Nelson, Van Denburg & Campbell Wealth Management Group, LLC | 122 | $472 | 0.00% |
Sold out (17)
Institutions that held Boundless Bio, Inc. at the end of Q1 2024 and filed for Q2 2024 without it.
| Institution | Shares, Q1 2024 | Value, Q1 2024 |
|---|---|---|
| Federated Hermes, Inc. | 375,000 | $5.34M |
| Silverarc Capital Management, LLC | 312,500 | $4.45M |
| LMR Partners LLP | 89,249 | $1.27M |
| Schonfeld Strategic Advisors LLC | 64,421 | $918.0K |
| Point72 Asset Management, L.P. | 59,000 | $840.8K |
| HBK Investments L P | 51,500 | $733.9K |
| NewGen Asset Management Ltd | 50,000 | $712.5K |
| Readystate Asset Management LP | 50,000 | $712.5K |
| UBS Oconnor LLC | 41,650 | $593.5K |
| Monashee Investment Management LLC | 31,250 | $445.3K |
| Balyasny Asset Management LLC | 30,000 | $427.5K |
| Blackstone Group Inc. | 30,000 | $427.5K |
| Weiss Asset Management LP | 22,500 | $320.6K |
| Teacher Retirement System of Texas | 20,000 | $285.0K |
| Soros Fund Management LLCSuperinvestorSoros Fund Management | 20,000 | $285.0K |
| Teachers Retirement System of the State of Kentucky | 14,920 | $213.0K |
| FNY Investment Advisers, LLC | 660 | $9.00K |